Lundbeck demonstrates leadership and unwavering commitment to advancing migraine management and supporting patient outcomes with six presentations at the 2025 International Headache Congress (IHC), including three oral presentations on eptinezumab (Vypeti®) and Lu AG09222 (anti-PACAP mAb)New data from the open-label extension of the RESOLUTION trial and the primary results of the SUNSET extension trial will be presented for the first time at IHC1,2Patients treated with eptinezumab experienced sustained red ...

The oil giant sees a lot of growth ahead.Shares of ExxonMobil (XOM 1.61%) have fallen about 10% from their 52-week high, mainly because of lower oil prices. This decline comes as the S&P 500 has been hitting new all-time highs. While ExxonMobil shares are currently down, its robust growth strategy and shareholder return potential position the oil stock as a compelling long-term investment opportunity these days. The growth plan to 2030ExxonMobil has a bold plan for the future. The oil giant's investment str ...

CONCLUDED Stock Market News From Sept. 11, 2025: S&P 500 Hits New High Last Updated: 16 hours ago Dollar Edges Higher Ahead of U.S. Inflation Data By Renae Dyer, Dow Jones Newswires The dollar was rising modestly against a basket of currencies ahead of data that are expected to show U.S. inflation accelerated in August. Customer Service Customer Center Network The Wall Street Journal Cryptocurrencies Data Magazine Markets Stock Picks Barron's Live Roundtable Barron's Stock Screen Personal Finance Streetwise ...

CALGARY, Alberta--(BUSINESS WIRE)--E3 LITHIUM LTD. (TSXV: ETL) (FSE: OW3) (OTCQX: EEMMF), "E3†, "E3 Lithium†or the "Company,†a leader in Canadian lithium, has received approval of its required permits from the Alberta Energy Regulator ("AER") to advance Phase 2 of its Clearwater Project Demonstration Facility. The Demonstration Facility is being completed in three phases (see illustration below), with Phase 1 currently being commissioned as announced on September 2, 2025. Phase 2 of the Demon. ...

PresentationWelcome to our fireside chat with Nurix. I am Robert Burns, Managing Director and Senior Biotech analyst at H.C. Wainwright. And I'm joined by Arthur Sands, the CEO of Nurix. Arthur, thank you for joining us today.Arthur SandsCEO, President & Director I do. I'll start out with a few slides just to frame things. We have our disclaimers, of course. So as we will be talking extensively about targeted protein degradation, I want to take a step back with this first slide and look at how we see it fit ...

The CNN Money Fear and Greed index showed some decline in the overall market sentiment, while the index remained in the “Neutral” zone on Wednesday.U.S. stocks settled mixed on Wednesday, with the Dow Jones index falling more than 200 points during the session. The S&P 500, however, surged to new highs following data on wholesale prices.The Producer Price Index slipped 0.1% in August, defying expectations for a 0.3% increase. Wholesale inflation slowed sharply every year as well, falling from 3.3% to 2.6%.A ...

EnglishItalianoEspañolPortuguêsDeutschالعربيةFrançaisImportant DisclaimersThe content provided on the website includes general news and publications, our personal analysis and opinions, and contents provided by third parties, which are intended for educational and research purposes only. It does not constitute, and should not be read as, any recommendation or advice to take any action whatsoever, including to make any investment or buy any product. When making any financial decision, you should perform your ...

The CNN Money Fear and Greed index showed some decline in the overall market sentiment, while the index remained in the “Neutral” zone on Wednesday.U.S. stocks settled mixed on Wednesday, with the Dow Jones index falling more than 200 points during the session. The S&P 500, however, surged to new highs following data on wholesale prices.The Producer Price Index slipped 0.1% in August, defying expectations for a 0.3% increase. Wholesale inflation slowed sharply every year as well, falling from 3.3% to 2.6%.A ...

PresentationWelcome to our fireside chat with Nurix. I am Robert Burns, Managing Director and Senior Biotech analyst at H.C. Wainwright. And I'm joined by Arthur Sands, the CEO of Nurix. Arthur, thank you for joining us today.Arthur SandsCEO, President & Director I do. I'll start out with a few slides just to frame things. We have our disclaimers, of course. So as we will be talking extensively about targeted protein degradation, I want to take a step back with this first slide and look at how we see it fit ...

AMSTERDAM--(BUSINESS WIRE)--Nebius Group N.V. ("Nebius Group†or the "Company†; NASDAQ: NBIS), a leading AI infrastructure company, today announced the pricing of its offering of $2.75 billion aggregate original principal amount of convertible senior notes, in two series: $1,375,000,000 aggregate original principal amount of 1.00% convertible notes due 2030 (the "2030 Notes†) and $1,375,000,000 aggregate original principal amount of 2.75% convertible notes due 2032 (the "2032 Notes†, and togeth. ...